OMT for Adhesive Capsulitis
Osteopathic Manipulative Treatment as an Adjunct Therapy for Adhesive Capsulitis
1 other identifier
interventional
300
1 country
3
Brief Summary
The goal of this clinical trial is to learn if Osteopathic Manipulative Treatment (OMT) is an effective addition to treatment of adhesive capsulitis. OMT is a non-invasive treatment in which a doctor gently moves and stretches muscles, joints, and tissues manually. Adhesive capsulitis is more commonly known as "frozen shoulder" and describes a shoulder that becomes stiff, painful, and limited in its motion due to some structural change in the joint. The main questions it aims to answer are: Is recovery faster when OMT is added to regular treatment? Are patients that underwent OMT more satisfied with their treatment? Researchers will compare patients who underwent OMT to patients who did not to see if OMT is an effective additional treatment for frozen shoulder. Participants will:
- Be assigned to one of the four experimental groups
- Visit clinic and/or physical therapy to undergo the treatments associated with their group:
- standard course of prescribed physical therapy
- standard course of prescribed physical therapy and an injection of an anti-inflammatory and anesthetics in the shoulder
- standard course of prescribed physical therapy and (up to) 4 OMT sessions
- standard course of prescribed physical therapy, an injection of an anti-inflammatory and anesthetics in the shoulder, and (up to) 4 OMT sessions.
- Visit clinic 1 month, 3 months, 6 months, and 1 year after treatment is complete
- Complete a survey about how satisfied they are with their treatment 1 month, 3 months, 6 months, and 1 year after it is complete
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Apr 2026
Typical duration for phase_4
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2028
March 27, 2026
March 1, 2026
1 year
March 23, 2026
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to Recovery as Measured in Months
The number of months separating the initial visit and the final treatment visit. The time taken for the provider to deem further treatment unnecessary
Up to 12 months
Secondary Outcomes (3)
Change in Range of Motion of the Shoulder Relative to Baseline
Baseline (before treatment) and then 1 month, 3 months, 6 months, and 12 months after treatment has ended
Change in Patient Satisfaction as Measured by Treatment Satisfaction Questionnaire for Medication (TSQM)
Measured 1 month, 3 months, 6 months, and 12 months after the end of treatment.
Change in Pain as Measured by Patient-Reported Pain Score
Measured at baseline (before treatment) then at 3 months, 6 months, and 12 months after treatment has ended.
Study Arms (4)
PT only
NO INTERVENTIONPatients in this group will receive the standard treatment for adhesive capsulitis: prescription for physical therapy
PT and Injection
ACTIVE COMPARATORPatients in this group will receive an intra-articular injection consisting of a corticosteroid (methylprednisolone acetate) and anesthetics (Lidocaine and Ropivacaine) in addition to the standard prescription for physical therapy
PT and OMT
EXPERIMENTALPatients in this group will receive (up to) 4 sessions of OMT spaced at least 2 weeks apart in addition to the standard prescription for physical therapy
PT, Injection, and OMT
EXPERIMENTALPatients in this group will receive an intra-articular injection consisting of a corticosteroid (methylprednisolone acetate) and anesthetics (Lidocaine and Ropivacaine) and (up to) 4 sessions of OMT in addition to the standard prescription for physical therapy
Interventions
Intra-articular injection consisting of 80 mg of methylprednisolone acetate, 2 mL of lidocaine (1%), and 4 mL of ropivacaine (0.5%)
Non-invasive, manual manipulation of the shoulder joint and its surrounding muscles and tissues
Eligibility Criteria
You may qualify if:
- patients diagnosed with adhesive capsulitis who have not received prior treatment for it
You may not qualify if:
- patients with contraindications to corticosteroid injections (uncontrolled diabetes, active infection, bleeding disorders, or corticosteroid hypersensitivity)
- patients diagnosed with adhesive capsulitis who have received (or are currently receiving) treatment for it
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
UH Ahuja Medical Center
Beachwood, Ohio, 44122, United States
UH St. John Health Center
Westlake, Ohio, 44145, United States
UH Westlake Health Center
Westlake, Ohio, 44145, United States
Related Publications (3)
Veera S, Chin J, Kleyn L, Spinelli S, Tafler L. Use of Osteopathic Manipulation for Treatment of Chronic Shoulder Injury Related to Vaccine Administration. Cureus. 2020 Jul 12;12(7):e9156. doi: 10.7759/cureus.9156.
PMID: 32789092BACKGROUNDVita, F., Pederiva, D., Tedeschi, R. et al. Adhesive capsulitis: the importance of early diagnosis and treatment. J Ultrasound 27, 579-587 (2024). https://doi.org/10.1007/s40477-024-00891-y
BACKGROUNDAllen GM. The diagnosis and management of shoulder pain. J Ultrason. 2018;18(74):234-239. doi: 10.15557/JoU.2018.0034.
PMID: 30451406BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kevin Killian, DO
University Hospitals
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- DO
Study Record Dates
First Submitted
March 23, 2026
First Posted
March 27, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
May 1, 2028
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share